Treatment of Sual-e-Yabis (Dry Cough) with Unani medicine Habb-e-Luab-e-Behidana
Phase 3
- Conditions
- Health Condition 1: R05- Cough
- Registration Number
- CTRI/2021/12/038808
- Lead Sponsor
- Central Council for Research in Unani Medicine CCRUM New Delhi
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Patients of either sex in the age group of 18-60 years.
2. Sual-e-Yabis (Dry Cough) of < 3 weeks duration
Exclusion Criteria
1. Acute Upper Respiratory Tract Infections (URI or URTI)
2. Acute Lower Respiratory Tract Infections (LRI or LRTI) including pneumonia, lung abscess, and acute bronchitis.
3. Chronic obstructive airway disease (COAD) including chronic bronchitis and emphysema.
4. Bronchiectasis, pulmonary tuberculosis, pulmonary oedema, interstitial pulmonary fibrosis
5. Tumours of larynx, bronchi, and lungs
6. Drug-induced Cough (e.g., ACE Inhibitors)
7. Diabetes Mellitus, Hypertension
8. Known cases of severe hepatic, renal or cardiac ailments
9. H/o addiction (smoking, alcohol, drugs)
10. Pregnant and lactating women
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Improvement in sign and symptoms of Sual-e-Yabis (Dry Cough)Timepoint: 2 weeks
- Secondary Outcome Measures
Name Time Method Haematological and biochemical assessment for safety assessmentTimepoint: Investigations will be done at baseline and end of treatment